2.Discussion on methods for searching traditional Chinese medical literature in English in PubMed-MEDLINE database.
Yi-lun SONG ; Xue-zhi YANG ; Xiao-yan LU
Chinese Journal of Integrated Traditional and Western Medicine 2006;26(7):651-654
The methods for searching traditional Chinese medical literature in English with subject headings in PubMed-MEDLINE database were discussed from the practical view, and seven useful searching methods with free words according to practical experiences were put forward in order to assist the domestic TCM researchers to utilize PubMed-MEDLINE database in searching overseas TCM literature in English.
Information Storage and Retrieval
;
methods
;
MEDLINE
;
Medicine, Chinese Traditional
;
Periodicals as Topic
;
PubMed
;
United States
3.Studies on chemical constituents in herb from Artemisia rupestris.
Wei-Xia SONG ; Teng-Fei JI ; Yi-Kang SI ; Ya-Lun SU
China Journal of Chinese Materia Medica 2006;31(21):1790-1792
OBJECTIVETo study the chemical constituents of Artemisia rupestris.
METHODThe chemical constituents were isolated by column chromatography on silical gel and sephadex LH - 20. Their structures were elucidated on the basis of spectral analysis.
RESULT8 compounds have isolated from this plant, and the structures of them have identified as rupestonic acid (1), chrysosplenetin B (2), artemetin (3), herniarin (4), isokaempferide (5), vanillic acid (6), kaempferol 3, 3', 4'-trimethyl ether (7) and ermanine (8).
CONCLUSIONCompounds 2-8 have been isolated from this plant for the first time.
Artemisia ; chemistry ; Flavonoids ; chemistry ; isolation & purification ; Plants, Medicinal ; chemistry ; Umbelliferones ; chemistry ; isolation & purification
4.Comparison of the effect between insulin lispro 75/25 and humulin 70/30 on the postprandial blood glucose excursion in patients with diabetes
Yu-Fang BI ; Song-Hua WU ; Xiao-Hui GUO ; Guang NING ; Kun-San XIANG ; Yan GAO ; Yi-Fei ZHANG ; Ming LI ; Jun-qing ZHANG ; Xin-yin SUN ; Xiao-jing ZHOU ; Phillipa Clarke ; Caroline Markey ; Yi-man ZHENG ; Jia-lun CHEN ;
Chinese Journal of Endocrinology and Metabolism 1985;0(02):-
The effects of human insulin 70/30 and insulin lispro 75/25 were compared in improving postprandial blood glucose excursions in 106 patients with type 1 or 2 diabetes in a one-month,open-labelled,self- controlled trial .The results showed that treatment of diabetic patients with insulin lispro 75/25 significantly improved 2 h postprandial blood glucose excursion compared to pre-study with human insulin 70/30 (baseline) without any significant adverse events or sustained hypoglycemic episodes.These physiological benefits were associated with a patient preference for insulin lispro 75/25.
5.Identification of Hypertension Subgroups through Topological Analysis of Symptom-Based Patient Similarity.
Yi-Fei WANG ; Jing-Jing WANG ; Wei PENG ; Yong-Hao REN ; Chao GAO ; Yun-Lun LI ; Rui WANG ; Xiao-Feng WANG ; Song-Jun HAN ; Jia-Yu LYU ; Jia-Ming HUAN ; Cui CHEN ; Hai-Yan WANG ; Zi-Xin SHU ; Xue-Zhong ZHOU ; Wei LI
Chinese journal of integrative medicine 2021;27(9):656-665
OBJECTIVE:
To obtain the subtypes of the clinical hypertension population based on symptoms and to explore the relationship between hypertension and comorbidities.
METHODS:
The data set was collected from the Chinese medicine (CM) electronic medical records of 33,458 hypertension inpatients in the Affiliated Hospital of Shandong University of Traditional Chinese Medicine between July 2014 and May 2017. Then, a hypertension disease comorbidity network (HDCN) was built to investigate the complicated associations between hypertension and their comorbidities. Moreover, a hypertension patient similarity network (HPSN) was constructed with patients' shared symptoms, and 7 main hypertension patient subgroups were identified from HPSN with a community detection method to exhibit the characteristics of clinical phenotypes and molecular mechanisms. In addition, the significant symptoms, diseases, CM syndromes and pathways of each main patient subgroup were obtained by enrichment analysis.
RESULTS:
The significant symptoms and diseases of these patient subgroups were associated with different damaged target organs of hypertension. Additionally, the specific phenotypic features (symptoms, diseases, and CM syndromes) were consistent with specific molecular features (pathways) in the same patient subgroup.
CONCLUSION
The utility and comprehensiveness of disease classification based on community detection of patient networks using shared CM symptom phenotypes showed the importance of hypertension patient subgroups.
6.Expert consensus statement on Pudilan Xiaoyan Oral Liquid in clinical practice.
Lian-Xin WANG ; Qing MIAO ; Yan-Ming XIE ; Da-Can CHEN ; Su-Lun SUN ; Hong-Chun ZHANG ; Zhong-Wu JIA ; Tie-Nan LI ; Jia ZHU ; Li-Qing SHI ; Ping SONG ; Feng GAO ; Bao-Lin WEI ; Cui-Ling FENG ; Yi-Qing QU ; Ni-Ni QU ; Xue-Feng YU ; Nian-Zhi ZHANG ; Xue-Qing YU
China Journal of Chinese Materia Medica 2019;44(24):5277-5281
Pudilan Xiaoyan Oral Liquid has effects in clearing away heat and detoxifying,and is used to treat pharynx and throat swelling caused by the syndrome of excessive heat and toxin accumulation. Its efficacy is to relieve swelling and pain( redness,swelling and hot pain). It is included in the Chinese Pharmacopoeia of 2015 Edition,and has been listed in provincial health insurance directories of Shaanxi,Jiangsu,Liaoning,Hunan,Tianjin,Xinjiang and Hebei. It has been recommended by health departments of Beijing,Chongqing and other provinces as a preferred drug for the prevention and treatment of H1 N1 and HFMD,and listed in the diagnosis and Treatment Guide of HFMD by the Ministry of Health,the Clinical Application Guide of Chinese Patent Medicine edited by the Lung Department Disease Branch of China Association of Chinese Medicine,and the Clinical Practice Guide of Single Administration/Combined Administration of Antibiotics in Treatment of Common Infectious Diseases by China Association of Chinese Medicine. To further improve the clinician's understanding of drugs and better guide the rational clinical application,we invited front-line clinical experts from respiratory department,infectious department and dermatology of traditional Chinese and Western medicine to develop and compile the expert consensus. The consensus fully considered the clinical evidence and the expert clinical experience to give recommendations for clinical problems with evidence support and consensus suggestions for clinical problems without evidence support by the nominal group method.This consensus is based on clinical research evidence and expert experience in a simple and clear format,which provides a preliminary reference for the clinical use of the drug.
China
;
Consensus
;
Drugs, Chinese Herbal/therapeutic use*
;
Humans
;
Medicine, Chinese Traditional
;
Nonprescription Drugs